REPORTS

Let’s Pullulate and Expand Your Business

Global Vasomotor Symptoms of Menopause Treatment Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jan 09, 2020  |  161 PAGES  |  REPORT CODE: CMM260515
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The Vasomotor Symptoms of Menopause Treatment is expected to grow from USD XX.0 million in 2018 to XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. The research provides insights for the global Vasomotor Symptoms of Menopause Treatment market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Vasomotor Symptoms of Menopause Treatment industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Vasomotor Symptoms of Menopause Treatment Market Segmentations:

By Players:

  • EndoCeutics, Inc.

  • TherapeuticsMD, Inc.

  • Euroscreen S.A.

  • Amgen Inc.

  • Mithra Pharmaceuticals S.A.

  • MenoGeniX, Inc.

  • Radius Health, Inc.

  • Pherin Pharmaceuticals, Inc.

  • Pivot Pharmaceuticals Inc

By Types:

  • Estetrol

  • Fezolinetant

  • FP-101

  • HBN-2

  • Others

By End-User:

  • Hospital

  • Homecare

  • Clinic

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Vasomotor Symptoms of Menopause Treatment Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Vasomotor Symptoms of Menopause Treatment Market Share by Types

    • 1.3.2 Global Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Estetrol from 2014 to 2026

    • 1.3.3 Global Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Fezolinetant from 2014 to 2026

    • 1.3.4 Global Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of FP-101 from 2014 to 2026

    • 1.3.5 Global Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of HBN-2 from 2014 to 2026

    • 1.3.6 Global Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Others from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Vasomotor Symptoms of Menopause Treatment Market Share by End-Users

    • 1.4.2 Global Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Hospital from 2014 to 2026

    • 1.4.3 Global Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Homecare from 2014 to 2026

    • 1.4.4 Global Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Clinic from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Vasomotor Symptoms of Menopause Treatment Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Vasomotor Symptoms of Menopause Treatment by Major Types

    • 3.4.1 Market Size and Growth Rate of Estetrol

    • 3.4.2 Market Size and Growth Rate of Fezolinetant

    • 3.4.3 Market Size and Growth Rate of FP-101

    • 3.4.4 Market Size and Growth Rate of HBN-2

    • 3.4.5 Market Size and Growth Rate of Others

4 Segmentation of Vasomotor Symptoms of Menopause Treatment Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Vasomotor Symptoms of Menopause Treatment by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Vasomotor Symptoms of Menopause Treatment for Hospital

    • 4.4.2 Market Size and Growth Rate of Vasomotor Symptoms of Menopause Treatment for Homecare

    • 4.4.3 Market Size and Growth Rate of Vasomotor Symptoms of Menopause Treatment for Clinic

5 Market Analysis by Major Regions

  • 5.1 Global Vasomotor Symptoms of Menopause Treatment Production Analysis by Major Regions

  • 5.2 Global Vasomotor Symptoms of Menopause Treatment Consumption Analysis by Major Regions

  • 5.3 Global Vasomotor Symptoms of Menopause Treatment Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Vasomotor Symptoms of Menopause Treatment Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Vasomotor Symptoms of Menopause Treatment Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Vasomotor Symptoms of Menopause Treatment Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Vasomotor Symptoms of Menopause Treatment Production, Import, Consumption and Export Analysis

6 Product Commodity of Vasomotor Symptoms of Menopause Treatment Market in Major Countries

  • 6.1 Top 5 Export Countries in Vasomotor Symptoms of Menopause Treatment market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Vasomotor Symptoms of Menopause Treatment market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Vasomotor Symptoms of Menopause Treatment market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Vasomotor Symptoms of Menopause Treatment market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Vasomotor Symptoms of Menopause Treatment market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Vasomotor Symptoms of Menopause Treatment market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Vasomotor Symptoms of Menopause Treatment Landscape Analysis

  • 7.1 North America Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major Types

  • 7.2 North America Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major End-Users

  • 7.3 North America Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major Countries

    • 7.3.1 United States Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate

    • 7.3.2 Canada Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate

    • 7.3.3 Mexico Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate

8 Europe Vasomotor Symptoms of Menopause Treatment Landscape Analysis

  • 8.1 Europe Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major Types

  • 8.2 Europe Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major End-Users

  • 8.3 Europe Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major Countries

    • 8.3.1 Germany Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate

    • 8.3.2 UK Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate

    • 8.3.3 France Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate

    • 8.3.4 Italy Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate

    • 8.3.6 Spain Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate

    • 8.3.7 Belgium Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate

    • 8.3.8 Poland Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate

    • 8.3.9 Russia Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate

    • 8.3.10 Turkey Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate

9 Asia Pacific Vasomotor Symptoms of Menopause Treatment Landscape Analysis

  • 9.1 Asia Pacific Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major Types

  • 9.2 Asia Pacific Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major Countries

    • 9.3.1 China Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate

    • 9.3.2 Japan Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate

    • 9.3.4 India Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate

    • 9.3.6 South Korea Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate

10 Latin America, Middle East & Africa Vasomotor Symptoms of Menopause Treatment Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Vasomotor Symptoms of Menopause Treatment Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate

    • 10.3.2 Brazil Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate

    • 10.3.3 Nigeria Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate

    • 10.3.4 South Africa Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate 

    • 10.3.5 Argentina Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 EndoCeutics, Inc.

    • 11.1.1 EndoCeutics, Inc. Company Profile and Development Status

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 TherapeuticsMD, Inc.

    • 11.2.1 TherapeuticsMD, Inc. Company Profile and Development Status

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Euroscreen S.A.

    • 11.3.1 Euroscreen S.A. Company Profile and Development Status

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Amgen Inc.

    • 11.4.1 Amgen Inc. Company Profile and Development Status

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Mithra Pharmaceuticals S.A.

    • 11.5.1 Mithra Pharmaceuticals S.A. Company Profile and Development Status

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 MenoGeniX, Inc.

    • 11.6.1 MenoGeniX, Inc. Company Profile and Development Status

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Radius Health, Inc.

    • 11.7.1 Radius Health, Inc. Company Profile and Development Status

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Pherin Pharmaceuticals, Inc.

    • 11.8.1 Pherin Pharmaceuticals, Inc. Company Profile and Development Status

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 Pivot Pharmaceuticals Inc

    • 11.9.1 Pivot Pharmaceuticals Inc Company Profile and Development Status

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 102 Figures and 140 Tables)

  • Figure Product Picture

  • Figure Global Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Estetrol from 2014 to 2026

  • Figure Global Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Fezolinetant from 2014 to 2026

  • Figure Global Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of FP-101 from 2014 to 2026

  • Figure Global Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of HBN-2 from 2014 to 2026

  • Figure Global Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Hospital from 2014 to 2026

  • Figure Global Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Homecare from 2014 to 2026

  • Figure Global Vasomotor Symptoms of Menopause Treatment Market Size and Growth Rate of Clinic from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Vasomotor Symptoms of Menopause Treatment Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Vasomotor Symptoms of Menopause Treatment Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Vasomotor Symptoms of Menopause Treatment

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Vasomotor Symptoms of Menopause Treatment by Different Types from 2014 to 2026

  • Table Consumption Share of Vasomotor Symptoms of Menopause Treatment by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Estetrol

  • Figure Market Size and Growth Rate of Fezolinetant

  • Figure Market Size and Growth Rate of FP-101

  • Figure Market Size and Growth Rate of HBN-2

  • Figure Market Size and Growth Rate of Others

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Vasomotor Symptoms of Menopause Treatment by Different End-Users from 2014 to 2026

  • Table Consumption Share of Vasomotor Symptoms of Menopause Treatment by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Hospital

  • Figure Market Size and Growth Rate of Homecare

  • Figure Market Size and Growth Rate of Clinic

  • Table Global Vasomotor Symptoms of Menopause Treatment Production by Major Regions

  • Table Global Vasomotor Symptoms of Menopause Treatment Production Share by Major Regions

  • Figure Global Vasomotor Symptoms of Menopause Treatment Production Share by Major Regions in 2014

  • Figure Global Vasomotor Symptoms of Menopause Treatment Production Share by Major Regions in 2018

  • Figure Global Vasomotor Symptoms of Menopause Treatment Production Share by Major Regions in 2026

  • Table Global Vasomotor Symptoms of Menopause Treatment Consumption by Major Regions

  • Table Global Vasomotor Symptoms of Menopause Treatment Consumption Share by Major Regions

  • Figure Global Vasomotor Symptoms of Menopause Treatment Consumption Share by Major Regions in 2014

  • Figure Global Vasomotor Symptoms of Menopause Treatment Consumption Share by Major Regions in 2018

  • Figure Global Vasomotor Symptoms of Menopause Treatment Consumption Share by Major Regions in 2026

  • Table North America Vasomotor Symptoms of Menopause Treatment Production, Import, Consumption and Export Analysis

  • Table Europe Vasomotor Symptoms of Menopause Treatment Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Vasomotor Symptoms of Menopause Treatment Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Vasomotor Symptoms of Menopause Treatment Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Vasomotor Symptoms of Menopause Treatment market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Vasomotor Symptoms of Menopause Treatment market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Vasomotor Symptoms of Menopause Treatment market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Vasomotor Symptoms of Menopause Treatment market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Vasomotor Symptoms of Menopause Treatment Consumption by Types from 2014 to 2026

  • Table North America Vasomotor Symptoms of Menopause Treatment Consumption Share by Types from 2014 to 2026

  • Figure North America Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2014

  • Figure North America Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2018

  • Figure North America Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2026

  • Table North America Vasomotor Symptoms of Menopause Treatment Consumption by End-Users from 2014 to 2026

  • Table North America Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users from 2014 to 2026

  • Figure North America Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2014

  • Figure North America Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2018

  • Figure North America Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2026

  • Table North America Vasomotor Symptoms of Menopause Treatment Consumption by Major Countries from 2014 to 2026

  • Table North America Vasomotor Symptoms of Menopause Treatment Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Vasomotor Symptoms of Menopause Treatment Consumption Share by Major Countries in 2014

  • Figure North America Vasomotor Symptoms of Menopause Treatment Consumption Share by Major Countries in 2018

  • Figure North America Vasomotor Symptoms of Menopause Treatment Consumption Share by Major Countries in 2026

  • Figure United States Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Vasomotor Symptoms of Menopause Treatment Consumption by Types from 2014 to 2026

  • Table Europe Vasomotor Symptoms of Menopause Treatment Consumption Share by Types from 2014 to 2026

  • Figure Europe Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2014

  • Figure Europe Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2018

  • Figure Europe Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2026

  • Table Europe Vasomotor Symptoms of Menopause Treatment Consumption by End-Users from 2014 to 2026

  • Table Europe Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2014

  • Figure Europe Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2018

  • Figure Europe Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2026

  • Table Europe Vasomotor Symptoms of Menopause Treatment Consumption by Major Countries from 2014 to 2026

  • Table Europe Vasomotor Symptoms of Menopause Treatment Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Vasomotor Symptoms of Menopause Treatment Consumption Share by Major Countries in 2014

  • Figure Europe Vasomotor Symptoms of Menopause Treatment Consumption Share by Major Countries in 2018

  • Figure Europe Vasomotor Symptoms of Menopause Treatment Consumption Share by Major Countries in 2026

  • Figure Germany Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure France Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Vasomotor Symptoms of Menopause Treatment Consumption by Types from 2014 to 2026

  • Table Asia Pacific Vasomotor Symptoms of Menopause Treatment Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2014

  • Figure Asia Pacific Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2018

  • Figure Asia Pacific Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2026

  • Table Asia Pacific Vasomotor Symptoms of Menopause Treatment Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2014

  • Figure Asia Pacific Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2018

  • Figure Asia Pacific Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2026

  • Table Asia Pacific Vasomotor Symptoms of Menopause Treatment Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Vasomotor Symptoms of Menopause Treatment Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Vasomotor Symptoms of Menopause Treatment Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Vasomotor Symptoms of Menopause Treatment Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Vasomotor Symptoms of Menopause Treatment Consumption Share by Major Countries in 2026

  • Figure China Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandVasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure India Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Vasomotor Symptoms of Menopause Treatment Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Vasomotor Symptoms of Menopause Treatment Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Vasomotor Symptoms of Menopause Treatment Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Vasomotor Symptoms of Menopause Treatment Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Vasomotor Symptoms of Menopause Treatment Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Vasomotor Symptoms of Menopause Treatment Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Vasomotor Symptoms of Menopause Treatment Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Vasomotor Symptoms of Menopause Treatment Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Vasomotor Symptoms of Menopause Treatment Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Vasomotor Symptoms of Menopause Treatment Consumption Share by Major Countries in 2026

  • Figure GCC Countries Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Vasomotor Symptoms of Menopause Treatment Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of EndoCeutics, Inc.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of EndoCeutics, Inc.

  • Figure Sales and Growth Rate Analysis of EndoCeutics, Inc.

  • Figure Revenue and Market Share Analysis of EndoCeutics, Inc.

  • Table Product and Service Introduction of EndoCeutics, Inc.

  • Table Company Profile and Development Status of TherapeuticsMD, Inc.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of TherapeuticsMD, Inc.

  • Figure Sales and Growth Rate Analysis of TherapeuticsMD, Inc.

  • Figure Revenue and Market Share Analysis of TherapeuticsMD, Inc.

  • Table Product and Service Introduction of TherapeuticsMD, Inc.

  • Table Company Profile and Development Status of Euroscreen S.A.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Euroscreen S.A.

  • Figure Sales and Growth Rate Analysis of Euroscreen S.A.

  • Figure Revenue and Market Share Analysis of Euroscreen S.A.

  • Table Product and Service Introduction of Euroscreen S.A.

  • Table Company Profile and Development Status of Amgen Inc.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc.

  • Figure Sales and Growth Rate Analysis of Amgen Inc.

  • Figure Revenue and Market Share Analysis of Amgen Inc.

  • Table Product and Service Introduction of Amgen Inc.

  • Table Company Profile and Development Status of Mithra Pharmaceuticals S.A.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mithra Pharmaceuticals S.A.

  • Figure Sales and Growth Rate Analysis of Mithra Pharmaceuticals S.A.

  • Figure Revenue and Market Share Analysis of Mithra Pharmaceuticals S.A.

  • Table Product and Service Introduction of Mithra Pharmaceuticals S.A.

  • Table Company Profile and Development Status of MenoGeniX, Inc.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MenoGeniX, Inc.

  • Figure Sales and Growth Rate Analysis of MenoGeniX, Inc.

  • Figure Revenue and Market Share Analysis of MenoGeniX, Inc.

  • Table Product and Service Introduction of MenoGeniX, Inc.

  • Table Company Profile and Development Status of Radius Health, Inc.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Radius Health, Inc.

  • Figure Sales and Growth Rate Analysis of Radius Health, Inc.

  • Figure Revenue and Market Share Analysis of Radius Health, Inc.

  • Table Product and Service Introduction of Radius Health, Inc.

  • Table Company Profile and Development Status of Pherin Pharmaceuticals, Inc.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pherin Pharmaceuticals, Inc.

  • Figure Sales and Growth Rate Analysis of Pherin Pharmaceuticals, Inc.

  • Figure Revenue and Market Share Analysis of Pherin Pharmaceuticals, Inc.

  • Table Product and Service Introduction of Pherin Pharmaceuticals, Inc.

  • Table Company Profile and Development Status of Pivot Pharmaceuticals Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pivot Pharmaceuticals Inc

  • Figure Sales and Growth Rate Analysis of Pivot Pharmaceuticals Inc

  • Figure Revenue and Market Share Analysis of Pivot Pharmaceuticals Inc

  • Table Product and Service Introduction of Pivot Pharmaceuticals Inc


Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top